Skip to main content
Frontiers in Endocrinology logoLink to Frontiers in Endocrinology
. 2021 Sep 20;12:771445. doi: 10.3389/fendo.2021.771445

Corrigendum: ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study

María Íñiguez 1, Patricia Pérez-Matute 1, Pablo Villoslada-Blanco 1, Emma Recio-Fernandez 1, Diana Ezquerro-Pérez 2, Jorge Alba 2, M Lourdes Ferreira-Laso 3, José A Oteo 1,2,*
PMCID: PMC8488428  PMID: 34616368

Error in Figure/Table

In the original article, there was a mistake in Table 2 as published. Alleles of rs4343 polymorphism were incorrectly written. The corrected Table 2 appears below.

Table 2.

Genotype frequencies of rs4341 and rs4343 polymorphisms in COVID-19 patients according to its hypertensive, dyslipidemic or diabetic status.

rs4341
Hypertension G/G G/C C/C P-value
Hospital ward 6 (20%) 16 (53.3%) 8 (26.7%) 0.031*
ICU 6 (50%) 5 (41.7%) 1 (8.3%) 0.03 $
Dyslipidemia G/G G/C C/C P-value
Hospital ward 2 (15.4%) 6 (46.1%) 5 (38.5%) 0.043*
ICU 4 (57.1%) 3 (42,9%) 0 (0%)
Diabetes Mellitus G/G G/C C/C P-value
Hospital ward 1 (8.3%) 7 (58.3%) 4 (33.3%) 0.033*
ICU 3 (100%) 0 (0%) 0 (0%) 0.009 $
rs4343
Hypertension G/G G/A A/A P-value
Hospital ward 15 (16.6%) 17 (56.7%) 8 (26.7%) 0.03 %
ICU 5 (41.7%) 6 (50%) 1 (8.3%)
Dyslipidemia G/G G/A A/A P-value
Hospital ward 2 (15.4%) 6 (46.1%) 5 (38.5%) 0.043 #
ICU 4 (57.1%) 3 (42,9%) 0 (0%)
Diabetes Mellitus G/G G/A A/A P-value
Hospital ward 1 (8.3%) 7 (58.3%) 4 (33.3%) 0.033 #
ICU 3 (100%) 0 (0%) 0 (0%) 0.009 %

Data are presented as number of patients and percentages.

*p-value for group difference between GG and GC and CC.

$p-value for group difference between GG+GC and CC.

#p-value for group difference between GG+GA and AA.

%p-value for group difference between GG+GA and AA.

Significant differences appear in bold case.

All data were adjusted for age, sex, BMI and number of comorbidities.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Endocrinology are provided here courtesy of Frontiers Media SA

RESOURCES